General Information of Drug (ID: DMDFZK8)

Drug Name
LY3113593
Indication
Disease Entry ICD 11 Status REF
Anaemia 3A90 Phase 2 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
DNV17I

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bone morphogenetic protein 6 (BMP6) TT07RIB BMP6_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02604160) A Study of LY3113593 in Participants With Chronic Kidney Disease. U.S. National Institutes of Health.
2 Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease. Br J Clin Pharmacol. 2019 May;85(5):935-948.